BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17653037)

  • 1. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.
    Jiang L; Yang P; He H; Li B; Lin X; Hou S; Zhou H; Huang X; Aize K
    Mol Vis; 2007 Jun; 13():968-74. PubMed ID: 17653037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
    Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses.
    Xu Y; Kapp JA
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3473-9. PubMed ID: 12407158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
    Kawashima H; Yamagami S; Tsuru T; Gregerson DS
    Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation.
    Zhang Y; Zhang M; Zhao S; Li X; Jia Z; Zhang L; Han ZC; Zhang X
    Int Immunopharmacol; 2013 Jan; 15(1):114-20. PubMed ID: 23178576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation.
    He H; Yang P; Jiang L; Zhang J; Zhao C; Chen L; Lin X; Zhou H; Kijlstra A
    BMC Immunol; 2008 Sep; 9():53. PubMed ID: 18816417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
    Kosiewicz MM; Streilein JW
    J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVA-specific CD8+ T cells do not express granzyme B during anterior chamber associated immune deviation.
    Ren Y; Yang P; Li B; Gao Y; Zhou H; Huang X; Zhu L; Kijlstra A
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1315-21. PubMed ID: 16538449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
    Niederkorn JY; Mayhew E; Mellon J; Hegde S
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID).
    Ferguson TA; Kaplan HJ
    Reg Immunol; 1988; 1(1):62-8. PubMed ID: 2978943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
    Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
    Kezuka T; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.
    Ferguson TA; Herndon JM; Dube P
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2643-51. PubMed ID: 8163352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-3 expression in the development of anterior chamber associated immune deviation.
    Fu T; Yang PZ; Huang XK; Huang Q; Zhou HY; Li B; Zhong HH; Chen X
    Chin Med J (Engl); 2005 Dec; 118(23):2000-4. PubMed ID: 16336837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.